SOM · ASX

Somnomed Limited (ASX:SOM)

AU$0.24

 -0.01 (-3.922%)
ASX:Live
21/11/2024 02:54:14 PM
Near Support HALO Ords HALO Growth HALO Balance Sheet GROWTH AUS +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

SOM Overview

SOM Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Very Weak

About SOM

Website

N/A

Telephone

61.2.9467.0400

Address

Crows Nest Level 3 20 Clarke Street Sydney, New South Wales (NSW) 2065

Description

SomnoMed Ltd. engages in the production and sale of devices for the oral treatment of sleep related disorders. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and Sunrise Sleep Test. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded in 2004 and is headquartered in Sydney, Australia.

SOM Price Chart

Key Stats

Market Cap

AU$60.51M

PE

29.90

EV/EBITDA

6.6

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.19 - 0.47

Trade Value (12mth)

AU$8,141.00

1 week

-12.07%

1 month

-21.54%

YTD

-32.06%

1 year

-25.11%

All time high

4.34

Key Fundamentals

EPS 3 yr Growth

797.30%

EBITDA Margin

-2.80%

Operating Cashflow

-$6m

Free Cash Flow Return

-13.70%

ROIC

-26.50%

Interest Coverage

-0.80

Quick Ratio

1.40

Other Data

Shares on Issue (Fully Dilluted)

176m

HALO Sector

Healthcare

Next Company Report Date

27-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

SOM Announcements

Latest Announcements

Date Announcements

23 October 24

Quarterly Activities Report

×

Quarterly Activities Report

23 October 24

Quarterly Appendix 4C Cash Flow Report

×

Quarterly Appendix 4C Cash Flow Report

17 October 24

Notice of Annual General Meeting

×

Notice of Annual General Meeting

17 October 24

Annual General Meeting Proxy Form

×

Annual General Meeting Proxy Form

08 October 24

Final Director's Interest Notice

×

Final Director's Interest Notice

08 October 24

Initial Director's Interest Notice

×

Initial Director's Interest Notice

07 October 24

Rest Assure - US Food and Drug Authority (FDA) Update

×

Rest Assure - US Food and Drug Authority (FDA) Update

03 October 24

Director Appointment/Resignation

×

Director Appointment/Resignation

30 September 24

Annual Report to shareholders

×

Annual Report to shareholders

30 September 24

Appendix 4G

×

Appendix 4G

30 September 24

Corporate Governance Statement

×

Corporate Governance Statement

23 September 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

09 September 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

28 August 24

Preliminary Final Report

×

Preliminary Final Report

28 August 24

FY24 Preliminary Report and FY25 Guidance

×

FY24 Preliminary Report and FY25 Guidance

28 August 24

Investor Presentation

×

Investor Presentation

21 August 24

FY24 full year results investor conference call details

×

FY24 full year results investor conference call details

24 July 24

Quarterly Activities Report

×

Quarterly Activities Report

24 July 24

Quarterly Cashflow Report

×

Quarterly Cashflow Report

01 July 24

Notification regarding unquoted securities - SOM

×

Notification regarding unquoted securities - SOM

01 July 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

01 July 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

28 June 24

Notification regarding unquoted securities - SOM

×

Notification regarding unquoted securities - SOM

27 June 24

Results of Meeting

×

Results of Meeting

20 May 24

Notice of Extraordinary General Meeting

×

Notice of Extraordinary General Meeting

20 May 24

Proxy Form

×

Proxy Form

SOM Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.04 -0.08 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.04 -0.08 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -269.9 -80.4 -34.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A 111.1 29.9 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A 16.5 6.6 Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.01 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 -0.07 -0.06 Lock Lock Lock
     Growth % Lock Lock Lock Lock -101.8 -1,440.3 -269.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.9 -9.4 -25.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A 0.0 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.25 0.20 0.21 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.11 0.03 0.11 Lock Lock Lock
     Growth % Lock Lock Lock Lock -47.7 -72.2 272.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 106 106 121 Lock Lock Lock
Basic m Lock Lock Lock Lock 106 106 121 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 73 84 92 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.7 15.2 9.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 43 50 58 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 39 46 49 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.5 16.9 7.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 53.9 54.7 53.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 46 45 46 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 0 1 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -106.1 634.8 -343.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.3 1.2 -2.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 4 5 6 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -4 -4 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -534.3 1.4 -104.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -5.7 -4.9 -9.1 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -3 -7 -11 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -4 -8 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -271.9 -80.3 -53.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -6.1 -9.6 -13.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 2 -4 -6 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 9 6 5 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -8 -6 -5 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 2 7 17 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 1 -7 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 53.9 -926.3 -10.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 -0.1 -0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 16 12 16 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 58 62 70 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 5 21 4 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -4 12 -9 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 30 40 25 Lock Lock Lock
Equity $m Lock Lock Lock Lock 28 22 45 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 33 43 49 Lock Lock Lock
     Growth % Lock Lock Lock Lock -15.3 30.8 13.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -7.6 -12.8 -17.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -16.0 -35.7 -27.2 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -10.2 -9.5 -17.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -12.3 -20.6 -26.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 5.1 -10.1 -13.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -0.5 0.4 -0.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 18.6 11.1 3.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -13.1 51.6 -21.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.3 1.5 1.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.1 1.3 1.4 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 51.6 43.5 46.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 7.8 -21.1 -31.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 8.3 9.2 10.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 12.3 10.5 8.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 11.1 9.2 6.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 17.4 14.3 14.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.2 1.3 1.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.2 1.3 1.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -4.8 -8.4 -12.3 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -6.0 -11.3 -16.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -7.6 -12.8 -17.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.1 2.8 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -16.0 -35.7 -27.2 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -16.0 -35.7 -27.2 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 29.6 34.7 44.7 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 43.8 39.8 34.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 73.4 74.5 79.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 122.4 115.5 102.8 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -49.0 -41.0 -23.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

SOM Shortsell

Frequently Asked Questions

The current share price of Somnomed Limited (SOM:ASX) is AU$0.24.
The 52-week high share price for Somnomed Limited (SOM:ASX) is AU$0.47.
The 52-week low share price for Somnomed Limited (SOM:ASX)? is AU$0.19.
The current TTM dividend payout for Somnomed Limited (SOM:ASX) is 0.00.
Somnomed Limited (SOM:ASX) does not pay a dividend.
Somnomed Limited (SOM:ASX) has a franking level of 0.0%.
Somnomed Limited (SOM:ASX) is classified in the Healthcare.
The current P/E ratio for Somnomed Limited (SOM:ASX) is 29.90.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.